Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Revance Therapeutics Inc’s stock clocked out at $3.61, down -4.50% from its previous closing price of $3.78. In other words, the price has decreased by -$4.50 from its previous closing price. On the day, 1.9 million shares were traded. RVNC stock price reached its highest trading level at $3.84 during the session, while it also had its lowest trading level at $3.61.
Ratios:
To gain a deeper understanding of RVNC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 4.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $16 previously.
On January 09, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $30 to $8.
Exane BNP Paribas Upgraded its Underperform to Neutral on August 16, 2023, while the target price for the stock was maintained at $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Hollander David sold 3,908 shares for $4.17 per share. The transaction valued at 16,296 led to the insider holds 104,945 shares of the business.
Jordan Erica sold 2,392 shares of RVNC for $9,096 on Apr 16 ’24. The Chief Commercial Officer now owns 114,864 shares after completing the transaction at $3.80 per share. On Mar 18 ’24, another insider, Sjuts Dustin S, who serves as the President of the company, sold 9,211 shares for $5.04 each. As a result, the insider received 46,446 and left with 167,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVNC now has a Market Capitalization of 396529600 and an Enterprise Value of 678068608. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.46. Its current Enterprise Value per Revenue stands at 2.639 whereas that against EBITDA is -3.614.
Stock Price History:
Over the past 52 weeks, RVNC has reached a high of $9.74, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is -27.24%, while the 200-Day Moving Average is calculated to be -20.82%.
Shares Statistics:
It appears that RVNC traded 3.07M shares on average per day over the past three months and 1652790 shares per day over the past ten days. A total of 104.90M shares are outstanding, with a floating share count of 95.70M. Insiders hold about 8.77% of the company’s shares, while institutions hold 79.62% stake in the company. Shares short for RVNC as of 1731628800 were 12210780 with a Short Ratio of 3.98, compared to 1728950400 on 9194558. Therefore, it implies a Short% of Shares Outstanding of 12210780 and a Short% of Float of 13.350001.
